• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Millennium Pharmaceuticals

Millennium Pharmaceuticals

  1. All
  2. 3rd Party
  3. Investing
  1. Epizyme Elects Kenneth Bate to Board of Directors

    Epizyme Elects Kenneth Bate to Board of Directors

  2. Research and Markets: Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014

    Research and Markets: Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2014

  3. Acetylon’s Selective HDAC Inhibitors to be Featured in Multiple Presentations of Positive Clinical and Preclinical Data at the 56th ASH Annual Meeting and Exposition

    Acetylon’s Selective HDAC Inhibitors to be Featured in Multiple Presentations of Positive Clinical and Preclinical Data at the 56th ASH Annual Meeting and Exposition

  4. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.